France's Cellectis wins US patents for gene editing technology - Reuters

France's Cellectis wins US patents for gene editing technology
Reuters
PARIS (Reuters) - The United States has granted French cell therapy group Cellectis two patents to deploy a technology known as CRISPR in T cells, which play a key role in the immune response to cancer, the company said on Tuesday. The patents come on ...and more »